戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 r binding site as assessed by 17b monoclonal antibody reactivity.
2 rise to frequent modulation in the levels of antibody reactivity.
3 de novo synthesis of TIN-ag protein, and its antibody reactivity.
4  and half of them developed CD4 binding site antibody reactivity.
5 osus (SLE) patients (n = 11) with raised aCL antibody reactivity.
6 lls and adsorbed 69-97% of plasma anti-PLA2R antibody reactivity.
7 essing of this allergen greatly affected its antibody reactivity.
8 nd meaningful readouts of influenza-specific antibody reactivity.
9 crambling their grafted sequences eliminates antibody reactivity.
10 ial fluid (P<0.0001) and more often had ECGF antibody reactivity.
11 ion of both gp120 and CD4 residues to enable antibody reactivity.
12 ain, resulting in substantial variability in antibody reactivity.
13  also selectively enhanced human anti-Neu5Gc antibody reactivity.
14 ation responsible for the lack of monoclonal antibody reactivity.
15 tion with H185 antibody resulted in no OC125 antibody reactivity.
16 te a specificity matrix useful in predicting antibody reactivity.
17                HCV infection was assessed by antibody reactivity.
18 en hybrids of the p53 core domain and tested antibody reactivity.
19 th different sizes and conformation-specific antibody reactivities.
20  that the arrays allow detection of specific antibody reactivity across a broad dynamic range using c
21 and cost-effective epitope-level analysis of antibody reactivity across hundreds of thousands of pept
22                                 In addition, antibody reactivities against more than one EBNA1 peptid
23           Most individuals showed unexpected antibody reactivities against peptides unique to autosom
24 aScreen-based immunoreactivity measurements, antibody reactivity against 3 proteins was positively as
25                       We validated increased antibody reactivity against AKT3, FCGR3A and ARL8B in pa
26 une individuals from Kenya was skewed toward antibody reactivity against asexual blood stage antigens
27 his study is to evaluate the human preformed antibody reactivity against DKO renal microvascular endo
28 ining measurements of expression profiles of antibody reactivity against each protein (295 antigens a
29                                  We observed antibody reactivity against lineage A, B.1.351, and P.1
30                         We identified strong antibody reactivity against PA-X in most H7N7-exposed in
31            Importantly, we identified strong antibody reactivity against PA-X, a putative virulence f
32  their sera were examined by immunoassay for antibody reactivity against synthetic peptides represent
33                                    Moreover, antibody reactivity against these antigens was temporall
34    Approximately half of the patients showed antibody reactivity against up to 7 out of the 33 tumor
35                     We compared the level of antibody reactivity among healthy blood donors from 2 wi
36  Northern analysis, N-terminal sequence, and antibody reactivity analyses indicated the absence of mR
37 sequence, which may relate to their specific antibody reactivities and host cell interactions.
38 O-acetyltransferase function was verified by antibody reactivity and (13)C NMR data for tviD-mutant p
39                                The levels of antibody reactivity and clinical sensitivity were lowest
40 ls, protect against reactive oxygen species, antibody reactivity and half-life in serum were influenc
41 nt dilution analysis, we analysed the BK.T-1 antibody reactivity and identified the bound cellular pr
42 y (but not sufficient) to induce a change of antibody reactivity and in some cases is not even necess
43 cination correlated with increased anti-NEAT antibody reactivity and reduced bacterial levels in orga
44 he E. coli host causes loss of O:23 and O:36 antibody reactivity and restores reactivity with WGA.
45                     To determine the role of antibody reactivity and the impact of somatic hypermutat
46                     Anti-alphav and -laminin antibody reactivity and their respective incorporated sp
47   On the basis of subunit molecular weights, antibody reactivity, and DNA binding activities, DRP-3 w
48 her by mass, N-terminal amino acid sequence, antibody reactivity, and enzymatic activity.
49 rse-phase chromatography, spectrophotometry, antibody reactivity, and kinetics of deglycosylation, de
50 te treatment of recombinant gp36 reduced the antibody reactivity, and nonglycosylated synthetic pepti
51 mothers exhibited infrequent, low-level SV40 antibody reactivity, and only six case mothers seroconve
52 odocytes), anti-heparan-sulfate-proteoglycan antibody reactivity, and wheat germ agglutinin lectin st
53  retrovirus (ERV) transcription and anti-ERV antibody reactivity are implicated in lupus pathogenesis
54 henotypic characteristics (coaggregation and antibody reactivity) as well as in their genotypic chara
55 gens identified were further scrutinized for antibody reactivity at primary, secondary, and latent di
56                                    AdV 41 PB antibody reactivity at Year 1 is significantly associate
57          Patients' sera were also tested for antibody reactivities by immunoblotting with M. paratube
58 ected mutagenesis of this sequence decreased antibody reactivity by 30%.
59 e found a strong correlation between surface antibody reactivity by flow cytometry and reduced P. fal
60 12 of the 14 patients; most rapidly lost all antibody reactivity by NIH technique in an average time
61 o correlation was noted between neutralizing antibody, reactivity by Western blot, and subsequent pro
62                                However, some antibody reactivities cannot be explained by amino acid
63                 The model suggests that EBOV antibody reactivity declines over 0.5-2 years after reco
64 icated that the pathogenicity and monoclonal antibody reactivity differences between two molecularly
65 tional context by which to quantify specific antibody reactivities even in complex sera.
66                                  By plotting antibody reactivity (fluorescence intensity) for known p
67 or recognition, transduction, and anticapsid antibody reactivity for AAV2.
68                           The HIV-1 and HIAP antibody reactivity found in patients with primary bilia
69 racellular antigens that elicited high-titer antibody reactivity greater in post-DLI than in pre-DLI
70                   A pharmacodynamic model of antibody reactivity identified a decay half-life of 77-1
71 n addition, more frequent acquisition of new antibody reactivities in transmitter mothers suggest tha
72  ZFYVE19, DAPK3, and OGFOD1 elicited minimal antibody reactivity in 12 normal subjects and 12 chemoth
73                    Additionally, patterns of antibody reactivity in both GCF and serum in the subject
74 ther insights into the clinical relevance of antibody reactivity in clinical transplantation and beyo
75 luenza virus and observed low but detectable antibody reactivity in elderly subjects, suggesting that
76 roarray analysis to characterize patterns of antibody reactivity in MS serum against a panel of CNS p
77 vestigate longitudinal changes in SARS-CoV-2 antibody reactivity in newborn infants are limited.
78 l killer cell infiltration and a presence of antibody reactivity in the absence of complement deposit
79 polymerase chain reaction and assessed HHV-6 antibody reactivity in the cerebrospinal fluid of enceph
80             Concomitantly, fibrillin-2 mRNA, antibody reactivity in the explants, and fibrillin-2-spe
81                  Furthermore, high anti-HIP1 antibody reactivity in the sera of a cohort of MCC patie
82                                 However, the antibody reactivity increased substantially when a mixtu
83 ent of ectodomain conformation by monoclonal antibody reactivity indicate that this suppression of fu
84                                    Moreover, antibody reactivity is impacted by the specific amino ac
85 ion of allergic disease independent of their antibody reactivity, is still lacking.
86                               One-year array antibody reactivity levels were analyzed from 119 childr
87 , in turtles from Hawaii, we detected strong antibody reactivity mainly in tumored animals, with a lo
88   Moreover, there was a threshold of surface antibody reactivity necessary to achieve robust inhibito
89  with early or later Lyme borreliosis to the antibody reactivities of sera from controls.
90 oximately 80% of the genome, we compared the antibody reactivities of sera from patients with early o
91            In this study, we investigate the antibody reactivities of three known RSV G mutant protei
92 .4.2009 New Orleans strains, we compared the antibody reactivity of a panel of mouse monoclonal antib
93                       The molecular size and antibody reactivity of gp45 expressed by the JG-29 clone
94 human immune response to syphilis, the serum antibody reactivity of syphilitic patients was examined
95                                The sizes and antibody reactivity of the intermediates suggest that HM
96 ivalent influenza vaccine and determined the antibody reactivity of these sera to influenza array ant
97 zes of the proteins estimated by the loss of antibody reactivity on Western blots were essentially id
98 antigen microarray to characterize microbial antibody reactivity, particularly to human-derived micro
99  COVAM allows CCP to be grouped according to antibody reactivity patterns against 11 SARS-CoV-2 antig
100              All four cats developed similar antibody reactivity patterns to B. koehlerae OMP antigen
101               In this study, we investigated antibody reactivity patterns to glycolipids and glycolip
102  glycolipids, identifies clinically relevant antibody reactivity patterns to glycolipids and glycolip
103 nd in MS patients, no disease-associated HSV antibody reactivity patterns were detected.
104       Seven patient clusters with particular antibody reactivity patterns were identified.
105 ope immunogenicity and the interpretation of antibody reactivity patterns with HLA panels.
106                                    Molecular antibody reactivity profiles have not yet been studied i
107 pe scanning technology, to analyze pan-viral antibody reactivity profiles of twins and SNP-genotyped
108 nd specificities of the Pmp subtype-specific antibody reactivity relating to gender and clinical outc
109                        However, due to broad antibody reactivity, reliable identification of m6A site
110                                        Those antibody reactivities remained stable over time.
111 n of PRD-0038 S using cryo-EM and monoclonal antibody reactivity reveals its distinct antigenicity re
112                                              Antibody reactivity significantly decreased during UDCA
113 e criteria of the variant CstF-64, including antibody reactivity, size, germ cell expression, and a c
114 quences with the IUPred-L scale, followed by antibody reactivity testing of 16-30-aa peptides from pe
115 a0603:DQalpha0103 proteins and contribute to antibody reactivity through an HLA-DM-dependent process.
116 In one large clonal lineage of gp41-reactive antibodies, reactivity to HIV-1 Env was acquired only af
117  exposed to the same immunological stimulus, antibody reactivities to viral antigens are enhanced in
118 and 75 normal blood donors were screened for antibody reactivity to 77 serologically defined tumor an
119                                       Higher antibody reactivity to AdV PB was associated with improv
120 iruses and the development of heterosubtypic antibody reactivity to animal influenza viruses.
121 MS contained significantly higher B cell and antibody reactivity to bovine casein than those from pat
122 ice was used to establish an animal model of antibody reactivity to citrullinated proteins.
123 rredoxin:NADP+ oxidoreductase (FNR), as were antibody reactivity to FNR and diaphorase activity.
124                        Despite a decrease in antibody reactivity to HIV Gag and Pol proteins, patient
125                                 Cellular and antibody reactivity to hsp65 was assessed.
126  is a high-throughput approach for assessing antibody reactivity to hundreds of thousands of candidat
127 tations over 1000 resamplings, we identified antibody reactivity to influenza whole-protein and pepti
128     All IVIg preparations varied in level of antibody reactivity to intact HLA antigens.
129                                              Antibody reactivity to many HCoV spike peptides also dis
130 ients with IBD express selective patterns of antibody reactivity to microbiota flagellins.
131          While heating caused a reduction in antibody reactivity to multimeric forms of parvalbumins
132 dividuals suspected of having HGE reaffirmed antibody reactivity to multiple antigens of B. burgdorfe
133 remic chimpanzees had a higher prevalence of antibody reactivity to NS3, NS4, and NS5.
134                                  We assessed antibody reactivity to nucleocapsid and spike antigens a
135                           There was frequent antibody reactivity to protein 41-G (p41-G), outer surfa
136                                         IgG4 antibody reactivity to purified Ll-SXP-1 was assessed by
137         This work identifies the epitopes of antibody reactivity to rocuronium, demonstrates anaphyla
138                               KTRs had lower antibody reactivity to SARS-CoV-2 than HCs, but KTRs and
139 acilitates simultaneous assessment of B-cell/antibody reactivity to several different antigens.
140 ties of antiviral IgG changed over time, and antibody reactivity to some viral proteins was detected
141                                              Antibody reactivity to the HCV envelope proteins E1 or E
142                                              Antibody reactivity to the orf 65 protein (ELISA) and to
143               In the absence of vaccination, antibody reactivity to the receptor binding domain (RBD)
144 phaScreen procedure was developed to measure antibody reactivity to the recombinant products.
145 rtunity to evaluate the relationship between antibody reactivity to these antigens and infection outc
146 ccessive samples was just a part of changing antibody reactivity to these peptides that again became
147                                        Serum antibody reactivity to this peptide epitope increased in
148                                     Overall, antibody reactivity to VAR2CSA recombinant proteins and
149 djustment for individuals' ages in years and antibody reactivity to whole-schizont extract (Chonyi, r
150                                    Here, IgG antibody reactivity toward ANO2 and EBV nuclear antigen
151  thrombocytopenia, and with high anti-HPA-1a antibody reactivity toward both alphaIIbbeta3 and alphav
152 ates of protection, we analyzed AdV-specific antibody reactivities using a multi-AdV protein microarr
153                                              Antibody reactivity was detectable before microfilaremia
154                                              Antibody reactivity was detected in 79% of the patients'
155  79% of the patients' sera, and the level of antibody reactivity was directly correlated with disease
156                                     Anti-CNS antibody reactivity was evident in the sera of the MS co
157                                              Antibody reactivity was first established upon expressio
158                                              Antibody reactivity was most prominent against oligomeri
159                                  The highest antibody reactivity was observed around 200 days after a
160 CF-7 tumor cells in 16 patients, whereas IgG antibody reactivity was observed in a few patients.
161            Finally, anti-cytomegaloviral IgG antibody reactivity was significantly inhibited in the D
162                               The pattern of antibody reactivity we observed may, in part, result fro
163  the gene(s) potentially responsible for the antibody reactivities were carried out, and an animal de
164                       The Ehx activities and antibody reactivities were compared with those of Hly.
165                                          Top antibody reactivities were evaluated for associations wi
166 c2A, two levels (strong and undetectable) of antibody reactivity were detected, suggesting that weak
167           Two bands of the same mobility and antibody reactivity were found in Western blots of plasm
168 nitored by immunoblot, increases in specific antibody reactivity were more prevalent among volunteers
169                                  Patterns of antibody reactivity were stable in most of the patients
170 teady-state levels of subunits by monoclonal antibody reactivity, when used in combination with a dis
171 exposed on the capsid surface for polyclonal antibody reactivity, while the small HA epitope was inac
172          Responses were defined as ratios of antibody reactivities with a target protein and its puri
173    HHV-8 infection was assessed by measuring antibody reactivity with a K8.1 (lytic-phase antigen) im
174 lly significant differences were observed in antibody reactivity with a panel of six partial P1 polyp
175 roliferative cellular reactivity and 95% had antibody reactivity with at least one of the spirochetal
176 ssis-infected human donors were screened for antibody reactivity with Bordetella iron-repressible cel
177  with their control counterparts for overall antibody reactivity with organisms of different chlamydi
178 C and FlaB, only a few patients had marginal antibody reactivity with OspA.
179              Serum samples which differed in antibody reactivity with P1 polypeptides generated by pa
180 sorbent assay, demonstrated immunoglobulin G antibody reactivity with peptides 6 and 11 and a T-cell
181                       These patients exhibit antibody reactivity years before developing MS symptoms

 
Page Top